Certification Program Curriculum

What a peptide service line actually earns — and how to know before you invest a dollar.

• Real margin math: cost of goods with a 503A partner, chair time and provider time per protocol
• Earnings benchmarks by category — weight management, recovery, longevity and aesthetics
• Pricing a protocol so it is profitable at the first visit, not the tenth
• Adding peptides alongside your aesthetic, weight-loss or functional lines without cannibalizing them
• The break-even model: the volume your practice needs before peptides carry their own weight

Turn a recurring therapy into recurring revenue — with pricing patients actually stay in.

• Why per-vial pricing wastes the recurring nature of peptide therapy
• Designing 3-, 6- and 12-month programs that match titration and maintenance
• Membership tiers that produce predictable monthly revenue
• Bundling labs, follow-ups and touchpoints so packages feel like care, not invoices
• Renewal and upgrade paths that grow patient lifetime value

Choose a pharmacy partner you can defend — clinically, financially and legally.

• Vetting a 503A or 503B partner: the questions to ask before you commit
• Third-party testing and cGMP verification — what the paperwork must show
• Ordering and inventory workflow that keeps product in date and in stock
• Contract terms that protect your practice
• Sourcing decisions that hold up when a board or payer examines them

A patient pipeline you control — from first consult to second location.

• Consult funnels that convert interest into a booked protocol
• The follow-up cadence that keeps patients adherent — and enrolled
• Reactivating lapsed patients without discounting your way there
• What changes structurally with a second provider or a second location
• The metrics that tell you when to scale — and when not to

Fill your schedule without triggering platform bans or claims problems.

• Google and Meta ad policies for prescription therapies — what gets accounts banned
• What you can and cannot say publicly about non-FDA-approved compounds
• Content and SEO strategy that earns patients instead of renting them
• Testimonial and before-and-after rules
• Physician-referral relationships that outlast any ad account

Know exactly where every peptide you prescribe stands — before a regulator asks.

• FDA compounding rules for 503A and 503B pharmacies, in plain language
• Bulk-substance category status and what it means for an individual peptide
• Patient-specific prescriptions versus office use
• The off-label versus unapproved distinction most clinicians get wrong
• Documenting medical necessity so every prescription stands on its own

Set the practice up right the first time — entity, ownership and coverage.

• Corporate practice of medicine restrictions, state by state
• MSO and friendly-PC structures — and when each is appropriate
• Whether your current malpractice policy covers this work
• The entity decisions that are far cheaper to get right at the start

The documentation layer most practices improvise — delivered as templates you adapt.

• Intake and screening forms built for peptide therapy
• Informed consent that covers non-FDA-approved use
• Charting standards that support your clinical decisions
• A template library you adapt — not build from nothing

Treat patients wherever they are — without prescribing your way into another state's problem.

• Prescribing across state lines: licensure and registration where your patients live
• Telehealth standard-of-care and remote-prescribing rules
• How supervision and delegation change when the visit is virtual
• Structuring a compliant multi-state or telehealth-first practice

Delegate safely, supervise correctly — and know what to do if a board ever calls.

• What can be delegated, and to whom, role by role
• Training staff to a consistent, documented standard
• The medical-director role and what it actually obligates you to do
• Responding to a board inquiry or payer audit